These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3698015)

  • 21. Potentiation of CCNU activity by misonidazole in metastases.
    Siemann DW; Alliet KL
    Clin Exp Metastasis; 1987; 5(1):57-63. PubMed ID: 3829497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW; Alliet KL
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
    Siemann DW; Alliet K; Maddison K; Wolf K
    Cancer Treat Rep; 1985 Dec; 69(12):1409-14. PubMed ID: 3841024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination.
    Siemann DW; Hill SA
    Cancer Res; 1986 Feb; 46(2):629-32. PubMed ID: 3940631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
    Hill SA; Keng PC; Siemann DW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1615-8. PubMed ID: 6480449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.
    Maynard K; Parsons PG
    Cancer Res; 1986 Oct; 46(10):5009-13. PubMed ID: 3756862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro.
    Mulcahy RT; Wustrow DJ; Hark RR; Kende AS
    Invest New Drugs; 1987; 5(3):281-7. PubMed ID: 3667163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT; Dembs NL; Ublacker GA
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitization by hypoxic pretreatment with misonidazole: an interaction of damage at the DNA level.
    Taylor YC; Evans JW; Brown JM
    Radiat Res; 1987 Mar; 109(3):364-73. PubMed ID: 3550868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells.
    Aquilina G; Ceccotti S; Martinelli S; Hampson R; Bignami M
    Cancer Res; 1998 Jan; 58(1):135-41. PubMed ID: 9426069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O6-methylguanine methyltransferase activity and sensitivity of Japanese tumor cell strains to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)- 3-nitrosourea hydrochloride.
    Tsujimura T; Zhang YP; Fujio C; Chang HR; Watatani M; Ishizaki K; Kitamura H; Ikenaga M
    Jpn J Cancer Res; 1987 Nov; 78(11):1207-15. PubMed ID: 3121556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
    Dosch J; Kaina B
    Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O6-methylguanine-DNA methyltransferase and human cancer chemotherapy.
    Wang DW; Zhang YP; Li JX; Wang XM; Wang BZ; Chen YN; Wu Y; Yang Y
    J Environ Pathol Toxicol Oncol; 1993; 12(2):73-80. PubMed ID: 8189361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
    Wheeler KT; Wallen CA; Wolf KL; Siemann DW
    Br J Cancer; 1984 Jun; 49(6):787-93. PubMed ID: 6733024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.